rs13306194

Variant summary

Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BA1

The NM_000384.3(APOB):​c.1594C>T​(p.Arg532Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00471 in 1,614,038 control chromosomes in the GnomAD database, including 409 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0058 ( 45 hom., cov: 33)
Exomes 𝑓: 0.0046 ( 364 hom. )

Consequence

APOB
NM_000384.3 missense

Scores

3
5
9

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:11O:1

Conservation

PhyloP100: 0.274
Variant links:
Genes affected
APOB (HGNC:603): (apolipoprotein B) This gene product is the main apolipoprotein of chylomicrons and low density lipoproteins (LDL), and is the ligand for the LDL receptor. It occurs in plasma as two main isoforms, apoB-48 and apoB-100: the former is synthesized exclusively in the gut and the latter in the liver. The intestinal and the hepatic forms of apoB are encoded by a single gene from a single, very long mRNA. The two isoforms share a common N-terminal sequence. The shorter apoB-48 protein is produced after RNA editing of the apoB-100 transcript at residue 2180 (CAA->UAA), resulting in the creation of a stop codon, and early translation termination. Mutations in this gene or its regulatory region cause hypobetalipoproteinemia, normotriglyceridemic hypobetalipoproteinemia, and hypercholesterolemia due to ligand-defective apoB, diseases affecting plasma cholesterol and apoB levels. [provided by RefSeq, Dec 2019]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0026582181).
BP6
Variant 2-21029662-G-A is Benign according to our data. Variant chr2-21029662-G-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 255979.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=3, Uncertain_significance=1, Benign=7}. Variant chr2-21029662-G-A is described in Lovd as [Benign]. Variant chr2-21029662-G-A is described in Lovd as [Pathogenic].
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.119 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
APOBNM_000384.3 linkuse as main transcriptc.1594C>T p.Arg532Trp missense_variant 12/29 ENST00000233242.5 NP_000375.3 P04114Q7Z7Q0Q59HB3

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
APOBENST00000233242.5 linkuse as main transcriptc.1594C>T p.Arg532Trp missense_variant 12/291 NM_000384.3 ENSP00000233242.1 P04114

Frequencies

GnomAD3 genomes
AF:
0.00581
AC:
883
AN:
152092
Hom.:
45
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000773
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00124
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.128
Gnomad SAS
AF:
0.00497
Gnomad FIN
AF:
0.00538
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00103
Gnomad OTH
AF:
0.00765
GnomAD3 exomes
AF:
0.0113
AC:
2832
AN:
251280
Hom.:
186
AF XY:
0.0103
AC XY:
1404
AN XY:
135804
show subpopulations
Gnomad AFR exome
AF:
0.000492
Gnomad AMR exome
AF:
0.000491
Gnomad ASJ exome
AF:
0.000695
Gnomad EAS exome
AF:
0.134
Gnomad SAS exome
AF:
0.00163
Gnomad FIN exome
AF:
0.00596
Gnomad NFE exome
AF:
0.000977
Gnomad OTH exome
AF:
0.00734
GnomAD4 exome
AF:
0.00460
AC:
6725
AN:
1461828
Hom.:
364
Cov.:
32
AF XY:
0.00442
AC XY:
3211
AN XY:
727226
show subpopulations
Gnomad4 AFR exome
AF:
0.000747
Gnomad4 AMR exome
AF:
0.000425
Gnomad4 ASJ exome
AF:
0.000344
Gnomad4 EAS exome
AF:
0.126
Gnomad4 SAS exome
AF:
0.00206
Gnomad4 FIN exome
AF:
0.00538
Gnomad4 NFE exome
AF:
0.000540
Gnomad4 OTH exome
AF:
0.0101
GnomAD4 genome
AF:
0.00577
AC:
878
AN:
152210
Hom.:
45
Cov.:
33
AF XY:
0.00677
AC XY:
504
AN XY:
74434
show subpopulations
Gnomad4 AFR
AF:
0.000771
Gnomad4 AMR
AF:
0.00124
Gnomad4 ASJ
AF:
0.000288
Gnomad4 EAS
AF:
0.127
Gnomad4 SAS
AF:
0.00518
Gnomad4 FIN
AF:
0.00538
Gnomad4 NFE
AF:
0.00103
Gnomad4 OTH
AF:
0.00710
Alfa
AF:
0.00573
Hom.:
55
Bravo
AF:
0.00632
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.000233
AC:
2
ExAC
AF:
0.0114
AC:
1379
Asia WGS
AF:
0.0510
AC:
177
AN:
3478
EpiCase
AF:
0.000545
EpiControl
AF:
0.000474

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:11Other:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Hypercholesterolemia, familial, 1 Uncertain:1Benign:2
Likely benign, criteria provided, single submitterclinical testingRobarts Research Institute, Western UniversityJan 02, 2018- -
Benign, criteria provided, single submitterclinical testingColor Diagnostics, LLC DBA Color HealthJun 26, 2017- -
Uncertain significance, criteria provided, single submitterresearchLaboratory of Genetics and Molecular Cardiology, University of São PauloMar 01, 2016- -
not specified Benign:2
Benign, no assertion criteria providedresearchLaboratorium voor Moleculaire Diagnostiek Experimentele Vasculaire Geneeskunde, Academisch Medisch Centrum-- -
Likely benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
not provided Benign:2
Benign, criteria provided, single submitterclinical testingQuest Diagnostics Nichols Institute San Juan CapistranoMar 29, 2023- -
Benign, criteria provided, single submitterclinical testingGeneDxJul 12, 2018This variant is associated with the following publications: (PMID: 29353225, 23593297, 26690388, 26612772, 29036232, 27516387, 29083407, 30526649, 30420299) -
Hypercholesterolemia, autosomal dominant, type B;C4551990:Familial hypobetalipoproteinemia 1 Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -
Hypercholesterolemia, autosomal dominant, type B Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Familial hypobetalipoproteinemia 1 Benign:1
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -
Cardiovascular phenotype Benign:1
Benign, criteria provided, single submitterclinical testingAmbry GeneticsOct 04, 2016This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Familial hypercholesterolemia Benign:1
Benign, criteria provided, single submitterclinical testingGENinCode PLCJun 19, 2024- -
Warfarin response Other:1
drug response, no assertion criteria providedresearchPharmacogenomics Lab, Chungbuk National UniversityAug 31, 2010- likely responsive

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.20
BayesDel_addAF
Benign
-0.18
T
BayesDel_noAF
Uncertain
0.090
CADD
Benign
23
DANN
Uncertain
1.0
DEOGEN2
Benign
0.41
.;T
Eigen
Benign
0.0031
Eigen_PC
Benign
-0.16
FATHMM_MKL
Uncertain
0.91
D
LIST_S2
Uncertain
0.96
.;D
MetaRNN
Benign
0.0027
T;T
MetaSVM
Benign
-0.73
T
PrimateAI
Benign
0.46
T
PROVEAN
Pathogenic
-5.6
D;D
REVEL
Uncertain
0.52
Sift
Pathogenic
0.0
D;D
Sift4G
Pathogenic
0.0
D;D
Vest4
0.81
MPC
0.28
ClinPred
0.056
T
GERP RS
-3.8
gMVP
0.70

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs13306194; hg19: chr2-21252534; COSMIC: COSV51928384; API